ACG
CORZ icon

Aventail Capital Group’s Core Scientific CORZ Stock Holding History

Aventail Capital Group’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-142,423
Closed -$2.43M – 147
2025
Q2 		$2.43M Buy
+142,423
New +$1.43M 0.11% 104
2025
Q1 		– Sell
-232,193
Closed -$3.26M – 133
2024
Q4 		$3.26M Buy
232,193
+29,011
+14% +$429K 0.17% 88
2024
Q3 		$2.41M Sell
203,182
-483,650
-70% -$5.01M 0.14% 73
2024
Q2 		$6.39M Buy
+686,832
New +$3.51M 0.45% 54

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $13.7B AUM 334.5% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aventail Capital Group's CORZ Position: Q3 2025 in Review

Aventail Capital Group sold out of Core Scientific (CORZ) in Q3 2025, closing a stake of 142,423 shares — an estimated $2.43M sold.

Aventail Capital Group first reported a position in CORZ in Q2 2024 and held it in 4 quarters. The position peaked at $6.39M in Q2 2024. 336 funds tracked by Wall St. Rank hold CORZ as of Q3 2025.

  • Aventail Capital Group reported no remaining Core Scientific position as of Q3 2025 after selling out during the quarter.
  • Aventail Capital Group sold 142,423 Core Scientific shares in Q3 2025, an estimated $2.43M.
  • Aventail Capital Group first reported a position in Core Scientific in Q2 2024 and held it in 4 quarters.
  • Aventail Capital Group's Core Scientific position peaked at $6.39M in Q2 2024.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q3 2025.

Based on Aventail Capital Group's 13F filing for Q3 2025, filed 14 Nov 2025.